Suppr超能文献

酚妥拉明作为特发性肥厚性主动脉瓣下狭窄激发试验的评估。

Evaluation of phentolamine as a provocative test for idiopathic hypertrophic subaortic stenosis.

作者信息

Kerin N Z, Mori I, Edelstein J, Blonder R, Rubenfire M

出版信息

Am Heart J. 1979 Feb;97(2):204-10. doi: 10.1016/0002-8703(79)90357-0.

Abstract

Intravenous injection of phentolamine potentially offers a better provocative test for aortic left ventricular outflow tract obstruction than do Valsalva's maneuver, inhalation of isoproterenol, or of amyl nitrite. In hemodynamic studies, phentolamine enhanced myocardial contractility, and decreased afterload with only induction of slight tachycardia. Phentolamine (5 mg.) was administered intravenously to five patients who had idiopathic hypertrophic subaortic stenosis, and 35 patients who had valvular dysfunctions, after which echocardiographic and phonocardiographic recordings were performed. Recordings were of high quality despite changing hemodynamics. Systolic pressures fell an average of 20 mm. Hg; no pressure fell below 90 mm. Hg; there was no notable increase in heart rate. In the five patients with typical idiopathic hypertrophic subaortic stenosis, the amyl nitrite increased the obstructive index from 39.6 +/- 12 to 51 +/- 18.9 (P less than 0.05); whereas, phentolamine increased the obstructive index to 69.8 +/- 25.6 (P less than 0.015). After a 2 week course of oral administration of 80 mg. of propranolol daily, and then either inhalation of amyl nitrite or injection of phentolamine, there was no change from the mean resting obstructive index. Phentolamine appears to be a safe, simple and specific diagnostic agent, and more potent than amyl nitrite in eliciting dynamic obstruction in IHSS; phentolamine and amyl nitrite do not affect the obstructive index in patients with beta blockade.

摘要

静脉注射酚妥拉明可能比瓦尔萨尔瓦动作、吸入异丙肾上腺素或亚硝酸异戊酯更适合作为主动脉左心室流出道梗阻的激发试验。在血流动力学研究中,酚妥拉明增强心肌收缩力,降低后负荷,仅诱发轻微心动过速。对5例特发性肥厚性主动脉瓣下狭窄患者和35例瓣膜功能障碍患者静脉注射酚妥拉明(5毫克),之后进行超声心动图和心音图记录。尽管血流动力学发生变化,但记录质量很高。收缩压平均下降20毫米汞柱;无压力降至90毫米汞柱以下;心率无明显增加。在5例典型的特发性肥厚性主动脉瓣下狭窄患者中,亚硝酸异戊酯使梗阻指数从39.6±12增加到51±18.9(P<0.05);而酚妥拉明使梗阻指数增加到69.8±25.6(P<0.015)。在每天口服80毫克普萘洛尔2周疗程后,然后吸入亚硝酸异戊酯或注射酚妥拉明,平均静息梗阻指数无变化。酚妥拉明似乎是一种安全、简单且特异的诊断药物,在诱发特发性肥厚性主动脉瓣下狭窄的动态梗阻方面比亚硝酸异戊酯更有效;在β受体阻滞剂治疗的患者中,酚妥拉明和亚硝酸异戊酯不影响梗阻指数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验